BCR and prostate adenocarcinoma: In this study, using the data generated by the TCGA-PRAD group, we identified a transcriptomic signature to predict BCR in patients with Gleason score ≥ 7 prostate cancer according to gene expression levels measured from prostatectomy specimens.